Triazine based radiopharmaceuticals and radioimaging agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9447121
SERIAL NO

14152864

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds according to Formula I and Formula II are potent inhibitors of PSMA.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MOLECULAR INSIGHT PHARMACEUTICALS INC160 SECOND STREET CAMBRIDGE MA 02142

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Babich, John W Cambridge, US 88 1375
Joyal, John L Melrose, US 13 285
Lu, Genliang Winchester, US 48 841
Zimmerman, Craig Topsfield, US 40 957

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 20, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00